A popular prescription drug for type 2, or adult-onset, diabetes increases a person’s risk of heart attack, an analysis of 42 clinical trials suggests.
The drug, called rosiglitazone or Avandia, is taken to lower blood sugar. The Food and Drug Administration approved the drug in 1999, and more than 11 million prescriptions were filled for it last year in the United States.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.